Asian subgroups and cancer incidence and mortality rates in California

Authors


  • Presented at Asian American Network for Cancer Awareness, Research, and Training (AANCART): Fifth Asian American Cancer Control Academy, Sacramento, California, October 22–23, 2004.

Abstract

The objective of this study was to characterize better the cancer burden among Asian subgroups in California. Nearly 3.7 million Asians reside in California, and no other state has as many Asians. Cancer statistics for Asians often are combined with statistics for Pacific Islanders, and rates for subgroups are not often examined, because most states do not have a large enough population. Asians are affected disproportionately by certain cancers, such as stomach and liver cancers. The California Cancer Registry, a population-based cancer registry, has collected data, including race/ethnicity data, since 1988. The 5-year, average, annual, age-adjusted cancer incidence and mortality rates from 1997 through 2001 were calculated for 5 Asian subgroups: Chinese, Filipino, Japanese, Korean, and Vietnamese. Cancer incidence and mortality varied greatly. Incidence rates for all sites combined among males varied from a low of 318.6 per 100,000 for Chinese to a high of 366.0 per 100,000 among Japanese. For females, rates ranged from 236.6 per 100,000 among Koreans to 302.4 per 100,000 among Japanese. Mortality rates also varied by Asian subgroup. Presenting one statistic for Asian/Pacific Islanders did not provide an accurate depiction of the cancer burden among the different Asian subgroups. Acculturation will continue to affect the patterns of cancer incidence among Asian subgroups in California. Cancer 2005. © 2005 American Cancer Society.

Asians and Pacific Islanders are often aggregated into one group in presentations of cancer incidence and mortality. The term “Asian,” as it is used for the U.S. Census, characterizes individuals from the Far East, Southeast Asia, or the Indian Subcontinent.1 This is a diverse group that represents individuals from Cambodia, China, India, Japan, Korea, Pakistan, the Philippine Islands, Thailand, Vietnam, and other countries. The Asian population includes many groups who differ in language and culture. These cultural differences may influence lifestyle factors, such as diet and tobacco use, which, in turn, affect cancer incidence and survival.

In addition to differences in culture, Asian subgroups also differ in their length of residence in the United States. For example, Chinese and Japanese have resided in the U.S. for several generations; whereas other groups, such as Korean, Hmong, Vietnamese, Laotians, and Cambodians, are more recent immigrants. It is well established that cancer incidence among recent immigrants reflects that of their homeland; however, over several generations, a shift toward rates of their new home occurs.2–5 Epidemiologic studies investigating this shift may provide information regarding the possible genetic and environmental contributions to cancer etiology, prevention, and control.

Most epidemiologic studies on cancer have been based on white and African-American populations, whose cancer risks and health issues can be very different from those of Asian populations. Although individuals of Asian race were significantly less likely to develop or die from cancer than non-Hispanic white individuals, they were at higher risk for developing some cancers, such as liver and stomach cancers.6–8

In 2000, nearly 12 million Asians lived in the U.S. and 36%, or close to 3.7 million Asians, resided in California.1 California had the largest population of Asian Americans in the U.S. and was a logical state in which to characterize better the cancer incidence and mortality rates among Asians. The large population of Asian/Pacific Islanders allowed for the calculation of incidence and mortality rates for the Asian subgroups.

MATERIALS AND METHODS

The California Cancer Registry (CCR), which is a population-based, statewide registry, collected incident cancers through a network of 10 regional registries. State law mandating the reporting of newly diagnosed cancers in California was passed in 1985, and statewide implementation was effective as of January 1, 1988, with standardized data collection and quality-control procedures.9–12 For the current study, all patients who were diagnosed with invasive cancer between January 1, 1988 and December 31, 2001 were included.

Race/ethnicity information on patients with cancer was based primarily on information contained in the patient's medical record. This information may be based on self-identification by the patient, on the assumptions by an admissions clerk or other medical personnel, or by inference using the race/ethnicity of parents, birthplace, maiden name, or surname. Individuals with race coded as white, black, or unknown with a surname that appeared on the 1980 U.S. Census list of 12,497 Hispanic surnames were categorized as Hispanic. Individuals with race coded as white, black, or unknown but with a Vietnamese or Hmong surname were categorized as Asian.

Ethnic-specific population estimates for the Chinese, Filipinos, Japanese, Korean, and Vietnamese were available only in censal years. Race-specific, age-specific, and gender-specific population estimates for California were obtained from the U.S. Census Bureau from the 1990 and 2000 U.S. Census.13, 14 For each Asian subgroup, data for each intercensal year between 1990 and 2000 were estimated by linear interpolation and extrapolation for 2001, by age and gender. Linear interpolation assumes a fixed rate of growth for each year. For the 2000 Census, no population estimates were produced for the individual Asian subgroups, because the Census allowed respondents to select any number of racial/ethnic groups. A minimum estimate was produced that included only those who self-identified as one Asian subgroup, and a maximum estimate was based on those who self-identified as many racial/ethnic groups, one of which was an Asian subgroup. The average between the minimum and maximum estimate was used for each Asian subgroup.

Cancer patterns were examined for the five most populous Asian subgroups in California: Chinese, Filipino, Japanese, Korean, and Vietnamese. All of these groups are relatively homogenous. Rates for South Asians were not reported, because they were inclusive of several ethnic groups. Cancer rates for Hmong have been reported previously.15 Currently, counts for many cancer sites are too few to produce accurate rates for other Asian subgroups and Pacific Islander subgroups.

Rates were calculated using SEER*Stat software and were standardized to the 2000 U.S. population.16 For the four major racial/ethnic groups, cancer incidence and mortality patterns and trend data were examined. Because of small numbers of patients for the Asian subgroups, 5-year, age-adjusted incidence and mortality rates were calculated. Trend data were not examined for the subgroups. Two measures of change were reported: the percent change (PC) and the estimated annual PC (EAPC). The PC was based on the average of the 2-year endpoints, 1988–1989 and 2000–2001, rather than 1 year of data. Second, the EAPC was calculated using the average percentage increase or decrease in cancer incidence and mortality rates per year during 1988–2001, and a regression line was fitted using the assumption that the natural logarithm of cancer rates changed at a constant rate during the 14-year period.

RESULTS

Incidence and Mortality Rates by Subgroup: Chinese

Among the Asian subgroups, cancer incidence rates among Chinese were consistently among the lowest. Chinese had the highest mortality rates for lung and bronchial cancer (34.3 per 100,000) among all Asian subgroups (see Tables 1 and 2).

Table 1. Five-Year Average, Annual, Age-Adjusted Incidence Rates: California, 1997–2001
 TotalMaleFemale
CountRateCountRateCountRate
  • NOS: not otherwise specified.

  • a

    Rates that were based on fewer than 15 patients were not calculated.

Chinese      
 All sites combined12,829281.16486318.66343251.9
 Colon and rectum198745.0104652.594138.9
 Corpus and uterus, NOS28410.80a28410.8
 Female breast189971.90a189971.9
 Liver65714.150723.61506.1
 Lung and bronchus169439.0100351.369129.0
 Prostate146372.1146372.10a
 Stomach63614.636118.527511.5
 Thyroid2985.7642.62348.5
Filipino      
 All sites combined12,557306.65896354.66661273.1
 Colon and rectum136634.772943.863727.9
 Corpus and uterus, NOS43016.50a43016.5
 Female breast253197.40a253197.4
 Liver3478.825514.9924.4
 Lung and bronchus164642.7113370.051323.2
 Prostate1772109.91772109.90a
 Stomach2366.41348.31025.0
 Thyroid50310.8975.040615.4
Japanese      
 All sites combined6733324.33098366.03635302.4
 Colon and rectum119957.558369.161649.3
 Corpus and uterus, NOS19716.70a19716.7
 Female breast1222105.50a1222105.5
 Liver1587.4617.6977.0
 Lung and bronchus73633.939546.034125.9
 Prostate86899.586899.50a
 Stomach40519.721626.618915.1
 Thyroid995.2273.2727.0
Korean      
 All sites combined3661273.41755337.51906236.3
 Colon and rectum51639.426548.825133.0
 Corpus and uterus, NOS768.10a768.1
 Female breast46149.10a46149.1
 Liver27920.218330.49612.7
 Lung and bronchus46139.229663.716523.7
 Prostate20041.620041.60a
 Stomach47337.428154.219226.1
 Thyroid1217.2233.39810.4
Vietnamese      
 All sites combined4355309.82244360.62111272.1
 Colon and rectum47435.223536.523933.8
 Corpus and uterus, NOS809.10a809.1
 Female breast50854.90a50854.9
 Liver46533.336053.510515.6
 Lung and bronchus64251.642672.921633.6
 Prostate28153.628153.60a
 Stomach23119.313926.19214.2
 Thyroid1537.8374.111611.5
Table 2. Five-Year Average, Annual, Age-Adjusted Mortality Rates: California, 1997–2001
Disease siteTotalMaleFemale
CountRateCountRateCountRate
  • NOS: not otherwise specified.

  • a

    Rates that were based on fewer than 15 patients were not calculated.

Chinese      
 All sites combined5942136.53285168.72657111.0
 Colon and rectum67816.036219.031613.6
 Corpus and uterus, NOS421.80a421.8
 Female beast32712.70a32712.7
 Liver56512.443020.71355.6
 Lung and bronchus146734.388746.158024.8
 Prostate1599.91599.90a
 Stomach4029.323512.31677.0
 Thyroid270.78a190.8
Filipino      
 All sites combined4451117.22321145.8213095.4
 Colon and rectum44211.725315.41898.7
 Corpus and uterus, NOS552.30a552.3
 Female breast43317.30a43317.3
 Liver2285.81639.4653.1
 Lung and bronchus110229.173145.837117.0
 Prostate23017.523017.50a
 Stomach1444.0845.2603.1
 Thyroid441.312a321.6
Japanese      
 All Sites combined2858138.91387170.31471118.3
 Colon and rectum41220.521826.819415.9
 Corpus and uterus, NOS322.50a322.5
 Female breast17315.20a17315.2
 Liver1466.6516.4956.5
 Lung and bronchus60728.533640.127120.9
 Prostate10214.310214.30a
 Stomach28013.914417.813611.1
 Thyroid13a7a6a
Korean      
 All sites combined1788146.1965203.4823111.4
 Colon and rectum17814.28416.99412.6
 Corpus and uterus, NOS14a0a14a
 Female breast707.60a707.6
 Liver21215.613122.18110.9
 Lung and bronchus38434.124355.314120.8
 Prostate248.0248.00a
 Stomach28122.417334.610814.5
 Thyroid9a1a8a
Vietnamese      
 All sites combined1678133.1967169.2711104.9
 Colon and rectum1018.6509.7517.8
 Corpus and uterus, NOS11a0a11a
 Female breast788.80a788.8
 Liver27920.820732.27211.4
 Lung and bronchus40132.826946.613221.1
 Prostate268.5268.50a
 Stomach12010.06712.4538.0
 Thyroid7a1a6a

Incidence and Mortality Rates by Subgroup: Filipino

Filipinos had the highest rate for prostate cancer (109.9 per 100,000) and thyroid cancer (10.8 per 100,000) among the Asian subgroups. The rate for uterine cancer among Filipino women was only slightly lower at 16.5 per 100,000 compared with Japanese women, who had the highest rate. Cancer mortality rates among Filipinos were the lowest of all Asian subgroups: 117.2 per 100,000. However, mortality rates among Filipinos for female breast cancer (17.3 per 100,000), male prostate cancer (17.5 per 100,000), and thyroid cancer (1.3 per 100,000) were the highest among all of the subgroups.

Incidence and Mortality Rates by Subgroup: Japanese

Japanese had the highest incidence rates for colorectal cancer (57.5 per 100,000), female breast cancer (105.5 per 100,000), and uterine cancer (16.7 per 100,000) among all of the Asian subgroups. The Japanese had the second highest mortality rate for all sites combined among the Asian subgroups at 138.9 per 100,000, and they had the highest mortality rates for colorectal cancer (20.5 per 100,000) and uterine cancer (2.5 per 100,000) compared with the other Asian subgroups.

Incidence and Mortality Rates by Subgroup: Korean

Koreans had the highest stomach cancer incidence rate at 37.4 per 100,000. The rate for female breast cancer was the lowest among Koreans (49.1 per 100,000). The cancer mortality rate among Koreans was the highest among the Asian subgroups (146.1 per 100,000). The stomach cancer mortality rate was highest among Koreans (22.4 per 100,000).

Incidence and Mortality Rates by Subgroup: Vietnamese

Among the Asian subgroups, Vietnamese had the highest rates for liver cancer (33.3 per 100,000) and for lung and bronchial cancers (51.6 per 100,000). Liver cancer mortality rates (20.8 per 100,000) in Vietnamese were the highest among all of the Asian subgroups.

DISCUSSION

Of the four major racial/ethnic groups, Asian/Pacific Islanders in California have the lowest cancer incidence and mortality rates.6 However, incidence and mortality rates vary greatly by Asian subgroup. Presenting one statistic for Asian/Pacific Islanders does not accurately depict the cancer burden among the different Asian subgroups.

Cigarette smoking prevalence rates among Asian groups have decreased in California. Studies have found that male adult smoking rates have declined from 16.2%17 to 14.5%18 among Chinese, from 32.9%17 to 24.4%17 among Filipinos, from 22.7%17 to 13.2%t18 among Japanese, from 36.0%19 to 31.6%18 among Vietnamese. With decreases in smoking prevalence documented among these Asian subgroups, the incidence of smoking-related cancers should decline. The decline in cancer incidence and mortality experienced by Asian/Pacific Islanders currently should continue if smoking prevalence continues to decrease among Asian subgroups.

Acculturation will affect the patterns of cancer and in general health among Asians and the associated subgroups.20 Although behaviors are difficult to quantify, lifestyles that differ from the traditional Asia lifestyle are being adopted U.S. Studies have found that cancer patterns change for different Asian subgroups as their time of residence in the U.S. is extended. For example, a study based in Los Angeles County found that, among Japanese and Filipino women, breast cancer incidence increased after immigrating to the U.S. Breast cancer rates quickly were approaching the rates of non-Hispanic white women.21 Other studies also have reported differences in exposures and lifestyles between migrants and their descendants that affect the risk of many types of cancer and general health.22–24 These statistics will provide the groundwork for further investigation of the factors associated with changing cancer patterns.

These findings are subject to some limitations. It is likely that data from the CCR had some racial misclassification for the four major racial/ethnic groups.25 In a study performed by Swallen et al. at the Northern California Cancer Center, it was found that approximately 20% of Vietnamese patients with cancer actually were not Vietnamese but were Chinese or “other Asian.”26 That study documented the misclassification in the San Francisco/Oakland Cancer Registry, which is part of the CCR. Consequently, this misclassification led to an overestimation of the incidence rates among the Vietnamese subgroup. Similar misclassification may affect other Asian subgroups, but the extent has not been examined for all Asian subgroups. Misclassification among Asian subgroups has been acknowledged as an issue that affects the accurate characterization of the cancer burden.27, 28 A committee that spans many state cancer registries was organized by the North American Association of Central Cancer Registries to develop better methodology for identifying Asian subgroups.

It is increasingly important to provide health statistics for the growing Asian-American population. However, one major challenge is the sporadic availability of population estimates. Denominator data obtained for Asian subgroups are produced only every 10n years when the Census is conducted. Although population estimates are projected during intercensal years for the four major racial/ethnic groups, no such estimates for Asian subgroups are made. Population estimates for 1991 through 1999 are projected using linear interpolation based on the 1990 and 2000 Census and are extrapolated for 2001. Depending on whether the Census data were underreported or overreported, incidence rates were overestimated or underestimated. Linear interpolation and extrapolation assumed for a steady rate of growth each year and will not reflect migrant fluctuation for specific Asian subpopulations.

In California, Asian-American women are the least likely to be diagnosed with cancer, although cancer remains the leading cause of death.29 This statistic should serve as a reminder for physicians to educate Asian Americans about the importance of cancer screening for early detection and to reduce cancer deaths. Cancer screening rates among Asian Americans are consistently the lowest among the four major racial/ethnic groups.30

In conclusion, although cancer incidence and mortality rates among Asian Americans generally are lower compared with other groups, cancer is the leading cause of death in Asian Americans. The evaluation of cancer burden among Asians showed great variation among Asian subgroups. Better characterization of the burden may improve the targeting of interventions.

Ancillary